Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?

scholarly article by Jong Eun Yeon published in September 2018

Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans? is …
instance of (P31):
editorialQ871232
scholarly articleQ13442814

External links are
P356DOI10.3350/CMH.2018.1009
P932PMC publication ID6166101
P698PubMed publication ID30200750

P2093author name stringJong Eun Yeon
P2860cites workEfficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional studyQ57213193
2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis CQ58788714
EASL Recommendations on Treatment of Hepatitis C 2018Q88344766
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment optionsQ29620126
Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virusQ34044333
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection.Q37352305
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network studyQ38795446
Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET studyQ39599901
A phase 3b study of sofosbuvir plus ribavirin in treatment-naive and treatment-experienced Korean patients chronically infected with genotype 2 hepatitis C virusQ40007121
Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience.Q40411310
Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection.Q41066364
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trialQ41750256
Sofosbuvir and ribavirin in HCV genotypes 2 and 3.Q42220605
Role of interleukin 28B-related gene polymorphisms in chronic hepatitis C and the response to antiviral therapy in KoreansQ42989632
Sofosbuvir for previously untreated chronic hepatitis C infectionQ42995119
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectmolecular biologyQ7202
ribavirinQ421862
sofosbuvirQ2502747
chronic hepatitis CQ55779873
P304page(s)294-296
P577publication date2018-09-01
P1433published inClinical and molecular hepatologyQ26853927
P1476titleDoes the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?
P478volume24

Search more.